19 May 2013
Keywords: millennium, publishes, results, vista, trial, now, subsidiary
Article | 08 September 2008
Millennium, now a US subsidiary of Japan's Takeda, has published results from the Phase III VISTA trial of Velcade (melphalan ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.